PFE Stock DD Pfizer, Inc. 11/04/2014 10:03:55

New Post Public Reply Private Reply Replies (0) Message Board

Nov 4, 2014 at 11:03 AM

PFE Pfizer, Inc. $PFE Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=PFE&...mp;yt0=Go!

Last Updated: 11/04/2014 10:03:51

Current Price and Quotes
Last Price 29.98
Previous Close 30.19 Open 30.14
Daily Range 29.96 - 30.30 52wk Range 27.51 - 32.96
Volume 6,034,077 Dividend 1.04
Average Vol (30d) 28,070,558 Yield 3.469

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 51,584,000 54,657,000 61,035,000 65,165,000
Cost of Revenue 9,586,000 9,821,000 12,500,000 14,788,000
Gross Profit 41,998,000 44,836,000 48,535,000 50,377,000
Operating Expenses

Research and Development 6,678,000 7,482,000 8,681,000 9,483,000
Sales, General and Admin. 14,355,000 15,171,000 17,581,000 18,973,000
Non-Recurring Items 1,182,000 1,810,000 2,841,000 3,145,000
Other 4,599,000 5,109,000 5,465,000 5,364,000
Operating Income 15,184,000 15,264,000 13,967,000 13,412,000
Income From Continuing Operations

Add'l Income/Expense Items 532,000 (4,022,000) (2,486,000) (3,941,000)
Earnings Before Interest and Tax 15,716,000 11,242,000 11,481,000 9,471,000
Interest Expense - - - -
Earnings Before Tax 15,716,000 11,242,000 11,481,000 9,471,000
Income Tax 4,306,000 2,221,000 3,621,000 1,153,000
Minority Interest 69,000 28,000 40,000 31,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 11,410,000 9,021,000 7,860,000 8,318,000
Non Recurring Events

Discontinued Operations 10,662,000 5,577,000 2,189,000 (30,000)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 22,003,000 14,570,000 10,009,000 8,257,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 22,003,000 14,570,000 10,009,000 8,257,000

Recent News
Source
Nov 4, 2014 Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix PR NEWSWIRE
Nov 4, 2014 "Goodbye Mr. Jones": The End Of The Dow As An American Index Seeking Alpha
Nov 3, 2014 7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides Seeking Alpha
Oct 30, 2014 How Cash-Rich Companies Might Repatriate Foreign Profits Tax-Free, Liberating The Nation From Political Gridlock At The Same Time Seeking Alpha
Oct 29, 2014 Pfizer Receives FDA Accelerated Approval for TRUMENBA(R) (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults BUSINESS WIRE
Oct 29, 2014 How Did High-Yield Dividend Champions Do During The Great Recession? Part 2 Seeking Alpha
Oct 29, 2014 Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly PR NEWSWIRE
Oct 29, 2014 Pfizer's PRISTIQ(R) (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder BUSINESS WIRE
Oct 29, 2014 Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success Seeking Alpha
Oct 28, 2014 Pfizer's (PFE) CEO Ian Read on Q3 2014 Results - Earnings Call Transcript Seeking Alpha

1
2
3
4
5
6
7
8
next >
last >>

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Factory-Built Homes Take Center Stage in New Doc Short

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

transcosmos: Not Just Calls—Evolving Business Strategy

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

SoftwareOne Triumphs in 2026 GitHub Partner Awards

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Data Centers Drive Surge in Power and Cooling Demand

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Jacobi's Harness Brings AI from Concept to Reality

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Air Canada-CAE Scholarship Drives Women in Aviation

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...